Sample Name
Sample Code
Sample Name
Sample Code
Sample Name
Sample Code
4
BIDU-SW
09888
5
JD HEALTH
06618
| (Q3)Sep 30, 2025 | (Q2)Jun 30, 2025 | (Q1)Mar 31, 2025 | (FY)Dec 31, 2024 | (Q4)Dec 31, 2024 | (Q3)Sep 30, 2024 | (Q2)Jun 30, 2024 | (Q1)Mar 31, 2024 | (FY)Dec 31, 2023 | (Q4)Dec 31, 2023 | |
|---|---|---|---|---|---|---|---|---|---|---|
| Total revenue | -28.62%965.37M | 283.21%2.6B | 1,271.06%2.84B | 725.75%5.27B | 1,666.89%3.03B | 716.80%1.35B | 372.90%679.71M | 31.51%207.01M | -32.51%638.3M | -20.04%171.58M |
| Cost of revenue | -29.47%928.65M | 301.94%2.53B | 1,484.46%2.74B | 853.11%5.02B | 1,956.24%2.9B | 874.77%1.32B | 410.93%629.69M | 35.53%172.75M | -33.65%526.99M | -14.58%141.21M |
| Gross profit | 2.45%36.71M | 47.40%73.73M | 194.99%101.06M | 122.81%248.01M | 321.23%127.91M | 17.45%35.84M | 144.14%50.02M | 14.39%34.26M | -26.52%111.31M | -38.36%30.37M |
| Operating expense | 131.87%18.64M | -201.97%-11.33M | 142.61%23.57M | -67.86%10.7M | 353.65%48.35M | -825.49%-58.48M | 272.94%11.11M | -17.06%9.72M | -4.42%33.28M | -21.27%10.66M |
| Selling and administrative expenses | -6.37%17.26M | -170.39%-10.1M | 550.47%80.89M | 130.24%98.55M | 431.63%53.33M | 81.61%18.43M | 97.82%14.35M | -19.80%12.44M | 5.66%42.8M | -28.95%10.03M |
| -General and administrative expense | -6.37%17.26M | -170.39%-10.1M | 550.47%80.89M | 130.24%98.55M | 431.63%53.33M | 81.61%18.43M | 97.82%14.35M | -19.80%12.44M | 5.66%42.8M | -28.95%10.03M |
| Other operating expenses | --1.38M | ---- | ---- | ---- | ---- | ---- | ---- | ---- | ---- | --626K |
| Total other operating income | ---- | -62.01%1.23M | 2,008.61%57.31M | 822.25%87.85M | --4.98M | 3,583.62%76.91M | -24.24%3.24M | -28.28%2.72M | 67.30%9.53M | ---- |
| Operating profit | -80.83%18.08M | 118.62%85.06M | 215.73%77.48M | 204.12%237.32M | 303.69%79.56M | 320.14%94.32M | 122.22%38.91M | 34.60%24.54M | -33.11%78.03M | -44.84%19.71M |
| Net non-operating interest income (expenses) | -143.40%-2.69M | 33.63%-1.76M | -36.61%-3.02M | 11.77%-6.62M | 65.43%-642K | 25.82%-1.11M | -93.31%-2.66M | 20.39%-2.21M | 37.69%-7.5M | 53.64%-1.86M |
| Non-operating interest income | -12.41%4.91M | 961.29%15.41M | 3,332.79%18.85M | 595.02%18.64M | 1,857.27%11.04M | 958.98%5.6M | 166.91%1.45M | -47.46%549K | 704.27%2.68M | 155.80%564K |
| Non-operating interest expense | 13.28%7.6M | 317.86%17.17M | 692.50%21.87M | 148.08%25.26M | 382.49%11.68M | 232.08%6.71M | 114.17%4.11M | -27.79%2.76M | -17.69%10.18M | -42.71%2.42M |
| Net investment income | ||||||||||
| Gain(Loss) on financial instruments designated as cash flow hedges | ||||||||||
| Gain(Loss) on derecognition of available-for-sale financial assets | ||||||||||
| Income from associates and other participating interests | 0 | -50.00%1K | 1K | -29.78%2.09K | 0 | 0 | 100.00%2K | 0 | 168.08%2.98K | 0 |
| Special income (charges) | 0 | 0 | -3.7M | 138K | ||||||
| Less:Other special charges | ---- | ---- | ---- | ---- | ---- | ---- | ---- | ---- | --3.7M | ---138K |
| Other non-operating income (expenses) | ||||||||||
| Income before tax | -83.49%15.39M | 129.77%83.29M | 233.46%74.47M | 227.06%230.7M | 338.70%78.91M | 344.73%93.21M | 124.68%36.25M | 44.46%22.33M | -32.58%70.54M | -43.29%17.99M |
| Income tax | -96.62%1.08M | 272.84%24M | 1,316.40%20.91M | 435.68%51.5M | 496.26%11.64M | 767.86%31.95M | 255.44%6.44M | -31.98%1.48M | -49.44%9.61M | -79.56%1.95M |
| Net income | -76.65%14.31M | 98.88%59.29M | 156.82%53.56M | 194.14%179.21M | 319.52%67.27M | 254.58%61.27M | 108.15%29.81M | 56.95%20.86M | -28.83%60.92M | -27.67%16.04M |
| Net income continuous operations | -76.65%14.31M | 98.88%59.29M | 156.82%53.56M | 194.14%179.21M | 319.52%67.27M | 254.58%61.27M | 108.15%29.81M | 56.95%20.86M | -28.83%60.92M | -27.67%16.04M |
| Noncontrolling interests | -88.77%1.65M | 459.92%7.14M | -111.84%-322K | 16,548.08%19.02M | 2,719.30%3.21M | 14.68M | 1.28M | -152K | -66.84%114.23K | 23,037.63%114K |
| Net income attributable to the company | -72.83%12.66M | 82.75%52.15M | 156.49%53.88M | 163.42%160.19M | 302.34%64.06M | 169.62%46.59M | 99.25%28.54M | 58.09%21.01M | -28.68%60.81M | -28.19%15.92M |
| Preferred stock dividends | ||||||||||
| Other under preferred stock dividend | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Net income attributable to common stockholders | -72.83%12.66M | 82.75%52.15M | 156.49%53.88M | 163.42%160.19M | 302.34%64.06M | 169.62%46.59M | 99.25%28.54M | 58.09%21.01M | -28.68%60.81M | -28.19%15.92M |
| Gross dividend payment | ||||||||||
| Basic earnings per share | -72.68%0.0056 | 65.94%0.0229 | 134.65%0.0237 | 152.20%0.0744 | 264.94%0.0281 | 146.99%0.0205 | 100.00%0.0138 | 57.81%0.0101 | -28.24%0.0295 | -27.97%0.0077 |
| Diluted earnings per share | -72.68%0.0056 | 65.94%0.0229 | 134.65%0.0237 | 152.20%0.0744 | 264.94%0.0281 | 146.99%0.0205 | 100.00%0.0138 | 57.81%0.0101 | -28.24%0.0295 | -27.97%0.0077 |
| Dividend per share | 0.00%0.0025 | 0.00%0.0025 | 0.00%0.0025 | -42.86%0.01 | 0.00%0.0025 | 0.00%0.0025 | -80.00%0.0025 | 0.0025 | 0.0175 | 0.0025 |
| Accounting Standards | NonUS-GAAP | NonUS-GAAP | NonUS-GAAP | NonUS-GAAP | NonUS-GAAP | NonUS-GAAP | NonUS-GAAP | NonUS-GAAP | NonUS-GAAP | NonUS-GAAP |
FY: Financial Year. Refers to the 10-K file disclosed by the listed company to the SEC.
Q: Quarter. Refers to the 10-Q file disclosed by the listed company to the SEC. Q1, Q2, Q3, and Q4 are quarterly reports each with a span of 3 months; Q6 and Q9 are cumulative reports, with Q6 including 6 months and Q9 9 months.